Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olymbec Investments Inc. Insider Profile
4 Followers
Olymbec Investments Inc., Ten Percent Owner at Cannara Biotech, holds 19.61M shares in Cannara Biotech (Ticker: LOVFF). Most recently, Olymbec Investments Inc. Bought $66,000 shares of Cannara Biotech on Jun 02, 2023 for an estimated value of 74.39K.
Olymbec Investments Inc. Cannara Biotech (LOVFF)Ten Percent Owner
Cannara Biotech (LOVFF)
Ten Percent Owner
Ranked #56,848 out of 98,501 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-7.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Olymbec Investments Inc.'s holdings
Insider Roles
Ten Percent Owner
Roles that Olymbec Investments Inc. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Olymbec Investments Inc.
Olymbec Investments Inc.'s Trading History
List of latest transactions for each holding click on a transaction to see Olymbec Investments Inc.'s performance on stock
You May Also Like
Olymbec Investments Inc. insider profile FAQ
What is the percentage of profitable transactions made by Olymbec Investments Inc.?
The percentage of profitable transactions made by Olymbec Investments Inc. is 0%.
What is the average return per transaction made by Olymbec Investments Inc.?
The average return per transaction made by Olymbec Investments Inc. is -7.80%.
What stocks does Olymbec Investments Inc. hold?
Olymbec Investments Inc. holds: LOVFF stocks.
What was Olymbec Investments Inc.’s latest transaction?
Olymbec Investments Inc. latest transaction was an Informative Buy of $74.39K.
What was Olymbec Investments Inc.'s most profitable transaction?
Olymbec Investments Inc.’s most profitable transaction was an Informative Buy of LOVFF stock on May 24, 2023. The return on the trade was 0.00%.
What is Olymbec Investments Inc.'s role in Cannara Biotech?
Olymbec Investments Inc.'s role in Cannara Biotech is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.